መነሻ › የልብ ጥቃት › North Carolina
በNorth Carolina ለየልብ ጥቃት የሚደረጉ ክሊኒካዊ ጥናቶች
ለየልብ ጥቃት የሚደረጉ 6 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በNorth Carolina ውስጥ ያሉ ከተሞች
Official study text (English)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Metrolina Nephrology Associates, PA, Charlotte
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Novant Health Heart Vas Inst, Charlotte
- Medication Management LLC, Greensboro
- Accellacare US Inc, Raleigh
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Duke University Health System, Durham
- Moses H Cone Memorial Hospital, Greensboro
- Medication Management LLC, Greensboro
- እና 6 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 105 · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Moses H. Cone Memorial Hospital, Greensboro
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ጁን 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Regional Hospital, Durham
- Duke University Medical Center, Durham
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT04774159Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
- Wake Forest Baptist Medical Centre, Winston-Salem
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 45 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ማርች 2026 · NCT04973397ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።